Atezolizumab生物仿制药是一种Fc工程化人源化单克隆抗体，可结合PD-L1并阻断与PD-1和B7.1受体的相互作用。Atezolizumab生物仿制药是一种非糖基化IgG 1 κ免疫球蛋白，计算分子量为145 kDa。 Atezolizumab生物仿制药-研究级该产品同种型对照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：1.0 - 5.0 mg/ml 纯度：>95% by SDS-PAGE and HPLC 内毒素：≤ 1.0 EU/mg as determined by the LAL method 制剂：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
